271 related articles for article (PubMed ID: 31703382)
1. Wnt Signalling in Acute Myeloid Leukaemia.
Gruszka AM; Valli D; Alcalay M
Cells; 2019 Nov; 8(11):. PubMed ID: 31703382
[TBL] [Abstract][Full Text] [Related]
2. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
Taskesen E; Staal FJ; Reinders MJ
BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
4. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T
J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298
[TBL] [Abstract][Full Text] [Related]
5. Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives.
Wagstaff M; Coke B; Hodgkiss GR; Morgan RG
Biosci Rep; 2022 Apr; 42(4):. PubMed ID: 35352805
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
Wu L; Amarachintha S; Xu J; Oley F; Du W
Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
[TBL] [Abstract][Full Text] [Related]
8. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
9. SOX12: a novel potential target for acute myeloid leukaemia.
Wan H; Cai J; Chen F; Zhu J; Zhong J; Zhong H
Br J Haematol; 2017 Feb; 176(3):421-430. PubMed ID: 27858992
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis.
Cardona-Echeverry A; Prada-Arismendy J
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3097-3109. PubMed ID: 32980885
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
Simon M; Grandage VL; Linch DC; Khwaja A
Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.
Liersch R; Müller-Tidow C; Berdel WE; Krug U
Br J Haematol; 2014 Apr; 165(1):17-38. PubMed ID: 24484469
[TBL] [Abstract][Full Text] [Related]
14. CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells.
Cheng K; Wong SC; Linn YC; Ho LP; Chng WJ; Schwarz H
Br J Haematol; 2014 Apr; 165(1):134-44. PubMed ID: 24428589
[TBL] [Abstract][Full Text] [Related]
15. Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.
Sami SA; Darwish NHE; Barile ANM; Mousa SA
Curr Treat Options Oncol; 2020 Jan; 21(1):3. PubMed ID: 31933183
[TBL] [Abstract][Full Text] [Related]
16. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.
Zhang H; Gu H; Li L; Ren Y; Zhang L
Tumour Biol; 2016 May; 37(5):5919-23. PubMed ID: 26592252
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
[TBL] [Abstract][Full Text] [Related]
18. Secondary Acute Myeloid Leukemia: A Primary Challenge of Diagnosis and Treatment.
Winer ES
Hematol Oncol Clin North Am; 2020 Apr; 34(2):449-463. PubMed ID: 32089222
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
[TBL] [Abstract][Full Text] [Related]
20. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]